The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host.
Vargas
H E
HE
Mayo Clinic Hospital, Transplant Medicine 5E, 5777 Mayo Blvd, Phoenix, AZ 85054.
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D006509:Hepatitis B / Q000517:prevention & control* / Q000601:surgery; D006515:Hepatitis B virus / Q000187:drug effects; D006801:Humans; D016867:Immunocompromised Host; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation; D011183:Postoperative Complications
D000998:Antiviral Agents; D019259:Lamivudine